PortfoliosLab logoPortfoliosLab logo
SBS vs. TRVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SBS vs. TRVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) and Trevi Therapeutics, Inc. (TRVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SBS achieves a 15.28% return, which is significantly higher than TRVI's 13.50% return.


SBS

1D
-0.18%
1M
-6.98%
YTD
15.28%
6M
14.60%
1Y
38.40%
3Y*
40.12%
5Y*
32.68%
10Y*
16.43%

TRVI

1D
5.57%
1M
-6.94%
YTD
13.50%
6M
11.28%
1Y
130.31%
3Y*
75.70%
5Y*
44.83%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SBS vs. TRVI - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
SBS
Companhia de Saneamento Básico do Estado de São Paulo - SABESP
15.28%80.60%-4.21%46.89%48.42%-13.79%-40.98%27.98%
TRVI
Trevi Therapeutics, Inc.
13.50%203.88%207.46%-30.57%146.74%-67.68%-35.47%-60.53%

Correlation

The correlation between SBS and TRVI is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (All Time)
Calculated using the full available price history since May 7, 2019

0.07

Fundamentals

EPS

SBS:

R$2.48

TRVI:

-$0.43

Total Revenue (TTM)

SBS:

R$38.70B

TRVI:

$0.00

Gross Profit (TTM)

SBS:

R$13.96B

TRVI:

-$31.00K

EBITDA (TTM)

SBS:

R$14.87B

TRVI:

-$49.16M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SBS vs. TRVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBS
SBS Risk / Return Rank: 7373
Overall Rank
SBS Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
SBS Sortino Ratio Rank: 7373
Sortino Ratio Rank
SBS Omega Ratio Rank: 6969
Omega Ratio Rank
SBS Calmar Ratio Rank: 7171
Calmar Ratio Rank
SBS Martin Ratio Rank: 7676
Martin Ratio Rank

TRVI
TRVI Risk / Return Rank: 8989
Overall Rank
TRVI Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
TRVI Sortino Ratio Rank: 8787
Sortino Ratio Rank
TRVI Omega Ratio Rank: 8686
Omega Ratio Rank
TRVI Calmar Ratio Rank: 9191
Calmar Ratio Rank
TRVI Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SBS vs. TRVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) and Trevi Therapeutics, Inc. (TRVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SBSTRVIDifference
Sharpe ratioReturn per unit of total volatility

-1.03

Sortino ratioReturn per unit of downside risk

-0.96

Omega ratioGain probability vs. loss probability

1.21

1.35

-0.14

Calmar ratioReturn relative to maximum drawdown

1.55

4.44

-2.89

Martin ratioReturn relative to average drawdown

4.65

10.40

-5.75

SBS vs. TRVI - Sharpe Ratio Comparison

The current SBS Sharpe Ratio is 1.14, which is lower than the TRVI Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of SBS and TRVI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SBS vs. TRVI - Drawdown Comparison

The maximum SBS drawdown since its inception was -76.49%, smaller than the maximum TRVI drawdown of -95.45%. Use the drawdown chart below to compare losses from any high point for SBS and TRVI.


Loading charts...

Drawdown Indicators


SBSTRVIDifference

Max Drawdown

Largest peak-to-trough decline

-76.49%

-95.45%

+18.96%

Max Drawdown (1Y)

Largest decline over 1 year

-24.88%

-29.50%

+4.62%

Max Drawdown (3Y)

Largest decline over 3 years

-24.88%

-61.96%

+37.08%

Max Drawdown (5Y)

Largest decline over 5 years

-30.35%

-80.26%

+49.91%

Max Drawdown (10Y)

Largest decline over 10 years

-61.91%

Current Drawdown

Current decline from peak

-22.90%

-7.73%

-15.17%

Average Drawdown

Average peak-to-trough decline

-25.70%

-61.49%

+35.79%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.28%

12.58%

-4.30%

Volatility

SBS vs. TRVI - Volatility Comparison

The current volatility for Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) is 8.92%, while Trevi Therapeutics, Inc. (TRVI) has a volatility of 13.78%. This indicates that SBS experiences smaller price fluctuations and is considered to be less risky than TRVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SBSTRVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.92%

13.78%

-4.86%

Volatility (6M)

Calculated over the trailing 6-month period

24.61%

39.38%

-14.77%

Volatility (1Y)

Calculated over the trailing 1-year period

33.86%

60.39%

-26.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.90%

88.26%

-51.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

43.51%

99.35%

-55.84%

Dividends

SBS vs. TRVI - Dividend Comparison

SBS's dividend yield for the trailing twelve months is around 2.33%, while TRVI has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
SBS
Companhia de Saneamento Básico do Estado de São Paulo - SABESP
2.33%4.68%1.96%1.66%1.88%0.97%2.93%1.99%3.86%2.76%0.65%1.91%
TRVI
Trevi Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

SBS vs. TRVI - Financials Comparison

This section allows you to compare key financial metrics between Companhia de Saneamento Básico do Estado de São Paulo - SABESP and Trevi Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
9.78B
0
(SBS) Total Revenue
(TRVI) Total Revenue
Please note, different currencies. SBS values in BRL, TRVI values in USD

Frequently Asked Questions


SBS and TRVI have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TRVI has higher volatility (13.78%) compared to SBS (8.92%). In terms of maximum drawdown, SBS dropped -76.49% vs TRVI's -95.45%.

TRVI currently has the higher Sharpe Ratio (2.17 vs 1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SBS and TRVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer